| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 115,864 | 127,122 | 115,920 | 121,313 | | Cost of Revenue | 33,552 | 37,297 | 41,754 | 50,885 | | | Gross Profit |
-
| 89,825 | 74,166 | 70,428 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 55,691 | 54,609 | 51,830 | 51,694 | | Non Recurring | 22,102 |
-
| 72,898 |
-
| | Others | 95,405 | 61,147 | 65,739 | 88,459 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (25,931) | (116,301) | (69,725) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (90,886) | (25,931) | (116,301) | (69,725) | | Interest Expense | 4,625 | 4,558 | 4,396 | 5,676 | | Income Before Tax | (95,511) | (30,489) | (120,697) | (75,401) | | Income Tax Expense | (26,793) | (14,488) | (16,924) | (28,654) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (68,718) | (16,001) | (103,773) | (46,747) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (68,718) | (16,001) | (103,773) | (46,747) | | Preferred Stock And Other Adjustments | (2,562) | (2,559) | (2,554) | (712) | | | Net Income Applicable To Common Shares | ($71,280) | ($18,560) | ($106,327) | ($47,459) |
|
0.02% Nasdaq 0.00%
Income Statement
